Vitamin E suppresses cyclosporine A-induced increase in the urinary excretion of arachidonic acid metabolites including F2-isoprostanes in the rat model

Transplantation Proceedings

Volumn 31, Issue 3, 1999, Pages 1724-1728

  Kanji, V K ^a   Wang, C ^a   Salahudeen, A K ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CYCLOSPORIN A; ISOPROSTANE;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; HEMATOCRIT; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ANIMALS; ARACHIDONIC ACID; CREATININE; CYCLOSPORINE; DINOPROST; FREE RADICALS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; NEPHRECTOMY; PROSTAGLANDINS F; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2; VITAMIN E;

EID: 0033135801     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00101-3     Document Type: Conference Paper

References (26)

1. Rogers TS, Elzinga L, Bennett WM, et al: Transplantation 45:153, 1988
2. Coffman TM, Carr DR, Yarger WE, et al: Transplantation 43:282, 1987
3. Benigni A, Chiabrando C, Piccinelli A, et al: Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Kidney Int 34:164, 1988
4. Grieve EM, Hawksworth GM, Simpson JG, et al: Biochem Pharmacol 45:1351, 1993
5. Smith SR, Kubacki VB, Rakhit A, et al: Transplantation 56:1422, 1993
6. Morrow JD, Hill KE, Burk RF, et al: Proc Nat Acad Sci USA 87:9383, 1990
7. Takahashi K, Nammour TM, Fukunaga M, et al: Clin Invest 90:136, 1992
8. Salahudeen A, Badr K, Morrow J, et al: J Am Soc Nephrol 6:1300, 1995
9. Morrow JD, Awad JA, Wu A, et al: J Biol Chem 271:23185, 1996
10. Wang C, Salahudeen AK: Kidney Int 47:927, 1995
11. Wang C, Salahudeen AK: Transplantation 58:940, 1994
12. de Arriba G, Parra T, de Lema G, et al: J Am Soc Nephrol 7:2961, 1996
13. Selvam R, Adhirai M: Nephron 75:77, 1997
14. Anderson R, Van Rensburg CE, Myer MS: Toxicol Appl Pharmacol 125:176, 1994
15. Spurney RF, Mayros SD, Collins D, et al: Prostaglandins 39:135, 1990
16. Roberts LJ, Morrow JD: Biochim Biophys Acta 1345:121, 1997
17. Salahudeen AK, Reckelhoff RF, Morrow J, et al: Drug News Perspect 13:1122, 1998
18. Krysztopik RJ, Bentley FR, Spain DA, et al: Transplantation 63:1215, 1997
19. Massicot F, Thevenin M, Martin C, et al: Drug Chem Toxicol 17:449, 1994
20. Perez de Lema G, Arribas-Gomez I, Ruiz-Gines JA, et al: Transplant Proc 29:1241, 1997
21. Berkenboom G, Brekine D, Fang ZY, et al: Cardiovasc Res 33:650, 1997
22. Reckelhoff JF, Kanji V, Racusen LC, et al: Am J Physiol 274:R767, 1998
23. Morrow JD, Moore KP, Awad JA, et al: J Lipid Mediator 6:417, 1993
24. Fukunaga M, Yura T, Badr KF: J Cardiovasc Pharmacol 26(suppl 3):S51, 1995
25. Kon V, Sugiura M, Inagami T, et al: Kidney Int 37:1487, 91, 1990
26. Baud L, Nivez MP, Chansel D, et al: Kidney Int 20:332, 1981